Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 1Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Breast Neoplasms 5Pancreatic Neoplasms 1Neoplasms, Plasma Cell 1Neoplasms 1Multiple Myeloma 1Lymphoma 1Lung Neoplasms 1Glioma 1Epidural Neoplasms 1Diffuse Intrinsic Pontine Glioma 1Colorectal Neoplasms 1Alzheimer Disease 1

Interventions

fludarabine 2Granulocyte Colony-Stimulating Factor 2Cyclophosphamide 2inebilizumab 1Sirolimus 1Positron-Emission Tomography 1Pemetrexed 1Lenalidomide 1Interleukin-6 1Hyperbaric Oxygenation 1Hydroxychloroquine 1Filgrastim 1Dexamethasone 1Bortezomib 1Blood Specimen Collection 113-valent pneumococcal vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Neoplasms, Plasma Cell × Blood Specimen Collection × Clear all
NCT03371420 2023-04-18

PET Imaging of Subjects Using 124I-PU-AD

Samus Therapeutics, Inc.

Phase EARLY_PHASE1 Terminated
5 enrolled
LymphoidPlasma cell

Alzheimer Disease, Lymphoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡